Cargando…

Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation

BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) adversely affects patients’ long-term outcome. METHODS: The paired t test and McNemar’s test were applied in a retrospective 1:1 matched-pair analysis including 36 patients with PTLD and 36 patients without PTLD after kidney or liver tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rausch, Lisa, Koenecke, Christian, Koch, Hans-Friedrich, Kaltenborn, Alexander, Emmanouilidis, Nikos, Pape, Lars, Lehner, Frank, Arelin, Viktor, Baumann, Ulrich, Schrem, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970231/ https://www.ncbi.nlm.nih.gov/pubmed/27486513 http://dx.doi.org/10.1186/s13737-016-0036-1

Ejemplares similares

Risk Balancing of Cold Ischemic Time against Night Shift Surgery Possibly Reduces Rates of Reoperation and Perioperative Graft Loss
por: Emmanouilidis, Nikos, et al.
Publicado: (2017)

Prediction of Three-Year Mortality After Deceased Donor Kidney Transplantation in Adults with Pre-Transplant Donor and Recipient Variables
por: Schwager, Ysabell, et al.
Publicado: (2019)

PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis
por: Stravodimou, A., et al.
Publicado: (2012)

Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
por: Zimmermann, Heiner, et al.
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience
por: Emmanouilidis, Nikos, et al.
Publicado: (2016)

Prognostic limitations of the Eurotransplant-donor risk index in liver transplantation
por: Reichert, Benedikt, et al.
Publicado: (2013)

Long-Term Results after Treatment of Very Low-, Low-, and High-Risk Thyroid Cancers in a Combined Setting of Thyroidectomy and Radio Ablation Therapy in Euthyroidism
por: Emmanouilidis, Nikos, et al.
Publicado: (2013)

A case of post renal transplant PTLD of lung
por: Sinha, Tanay, et al.
Publicado: (2023)

Long-Term Results After Adult Ex Situ Split Liver Transplantation Since Its Introduction in 1987
por: Schrem, Harald, et al.
Publicado: (2014)

Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients
por: Saldaña, Ricardo Salinas, et al.
Publicado: (2017)

Comparable outcome of liver transplantation with Histidine-Tryptophan-Ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial
por: Kaltenborn, Alexander, et al.
Publicado: (2014)

Biliary complications following liver transplantation: Single-center experience over three decades and recent risk factors
por: Kaltenborn, Alexander, et al.
Publicado: (2017)

Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era
por: Klose, Johannes, et al.
Publicado: (2014)

Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives
por: Compagno, Francesca, et al.
Publicado: (2020)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN RENAL TRANSPLANT PATIENTS WITH COVID-19
por: MAHONEY, IAN, et al.
Publicado: (2022)

Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control
por: Schrem, Harald, et al.
Publicado: (2016)

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients
por: Bishnoi, Rohit, et al.
Publicado: (2017)

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation
por: Janardan, Sanyukta, et al.
Publicado: (2022)

Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases
por: Kulik, Ulf, et al.
Publicado: (2018)

High-Urgency Renal Transplantation: Indications and Long-Term Outcomes
por: Kousoulas, Lampros, et al.
Publicado: (2013)

Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
por: Grannas, Gerrit, et al.
Publicado: (2014)

PD‐L1 and PD1 expression in post‐transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter‐ and intra‐individual descriptive study covering the whole spectrum of PTLD categories
por: Schiefer, Ana‐Iris, et al.
Publicado: (2019)

O01 Post-transplant lymphoproliferative disorder (PTLD) in a patient with rheumatoid arthritis
por: Kim, Sung-Hee, et al.
Publicado: (2021)

Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD
por: Oren, Daniel, et al.
Publicado: (2022)

Evaluation of published assessment tools for comorbidity in liver transplantation: a systematic review protocol
por: Qu, Zhi, et al.
Publicado: (2018)

Post-transplant Lymphoproliferative Disorder (PTLD) in the US Population: Demographics, Treatment Characteristics, and Survival Analysis
por: Ullah, Asad, et al.
Publicado: (2023)

Decision modelling for economic evaluation of liver transplantation
por: Qu, Zhi, et al.
Publicado: (2018)

Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
por: Clerico, Michele, et al.
Publicado: (2022)

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
por: Kline, Kathryn, et al.
Publicado: (2023)

Late Onset Graft Plasmacytoma-Like PTLD Presenting as Acute Hyperglycemia in a Kidney-Pancreas Transplant Recipient
por: Ventura-Aguiar, P., et al.
Publicado: (2019)

Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant population
por: Ali, Hatem, et al.
Publicado: (2020)

Sterile necrotizing and non-necrotizing granulomas in a heart transplant patient with history of PTLD: A unique finding
por: Piening, Nicholas, et al.
Publicado: (2019)

P1346: EVALUATION OF CURRENT NATIONAL PRACTICE IN THE PREVENTION OF PTLD POST PAEDIATRIC HSCT
por: Kissane, E., et al.
Publicado: (2022)

HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
por: Vietzen, Hannes, et al.
Publicado: (2023)

Development and validation of a prognostic model for kidney function 1 year after combined pancreas and kidney transplantation using pre-transplant donor and recipient variables
por: Zorn, Katharina S., et al.
Publicado: (2018)

Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient
por: Afshar, Kamyar, et al.
Publicado: (2011)

Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?
por: Mohamed, Mahmoud, et al.
Publicado: (2020)

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD
por: Lupo, Julien, et al.
Publicado: (2022)

Risk-Adjusted Analysis of Relevant Outcome Drivers for Patients after More Than Two Kidney Transplants
por: Kousoulas, Lampros, et al.
Publicado: (2015)

Adhesion Prevention Efficacy of Composite Meshes Parietex(®), Proceed(®) and 4DryField(®) PH Covered Polypropylene Meshes in an IPOM Rat Model
por: Winny, Markus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dnh3pbet31662mjjta4583t4jl